Investigational Antibody Therapy AZD7442 Effective In Reducing Severe Illness, Death In Patients With COVID-19, Drugmaker Says

The Hill (10/11, Choi) reports AstraZeneca issued data Monday showing its investigational “COVID-19 treatment has been found to be effective in late-stage trials at preventing severe illness or death.” When compared to placebo, antibody treatment AZD7442...